The normal phenotype of Pmm1-deficient mice suggests that Pmm1 is not essential for normal mouse development

Molecular and Cellular Biology

Volumn 26, Issue 15, 2006, Pages 5621-5635

  Cromphout, K ^a   Vleugels, W ^a   Heykants, L ^a   Schollen, E ^a   Keldermans, L ^a   Sciot, R ^a   D'Hooge, R ^a   De Deyn, P P ^b   Von Figura, K ^c   Hartmann, D ^d   Korner C ^e   Matthijs, G ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; GLYCAN; GLYCOPROTEIN; LECTIN; MANNOSE 6 PHOSPHATE; MANNOSE PHOSPHATE; PHOSPHOMANNOMUTASE; PHOSPHOMANNOMUTASE 1; PHOSPHOMANNOMUTASE 2; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN DEVELOPMENT; CARBOHYDRATE SYNTHESIS; CONFORMATIONAL TRANSITION; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1A; CONTROLLED STUDY; DEVELOPMENT; DEVELOPMENTAL STABILITY; EMBRYO; EMBRYO (ANATOMY); ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEFICIENCY; FEMALE; GENE; GENE MUTATION; HISTOCHEMISTRY; HORMONAL REGULATION; IN VITRO STUDY; KNOCKOUT MOUSE; MALE; MICROSCOPIC ANATOMY; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PHYLOGENY; PMM1 GENE; PMM2 GENE; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; TISSUE CHARACTERIZATION;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; EMBRYO; FEMALE; HUMANS; INSULIN-SECRETING CELLS; ISOENZYMES; LECTINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PHOSPHOTRANSFERASES (PHOSPHOMUTASES); TISSUE DISTRIBUTION;

ANIMALIA; MURINAE;

EID: 33746486155     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02357-05     Document Type: Article

References (30)

1. Aebi, M., and T. Hennet. 2001. Congenital disorders of glycosylation: genetic model systems lead the way. Trends Cell Biol. 11:136-141.
2. Akaboshi, S., K. Ohno, and K. Takeshita. 1995. Neuroradiological findings in the carbohydrate-deficient glycoprotein syndrome. Neuroradiology 37:491-495.
3. Antoun, H., N. Villeneuve, A. Gelot, S. Panisset, and C. Adamsbaum. 1999. Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1. Pediatr. Radiol. 29:194-198.
4. Artuch, R., I. Ferrer, J. Pineda, J. Moreno, C. Busquets, P. Briones, and M. A. Vilaseca. 2003. Western blotting with diaminobenzidine detection for the diagnosis of congenital disorders of glycosylation. J. Neurosci. Methods 125:167-171.
5. Barone, R., L. Pavone, A. Fiumara, R. Bianchini, and J. Jaeken. 1999. Developmental patterns and neuropsychological assessment in patients with carbohydrate-deficient glycoconjugate syndrome type IA (phosphomannomutase deficiency). Brain Dev. 21:260-263.
6. Crawley, J. N., J. K. Belknap, A. Collins, J. C. Crabbe, W. Frankel, N. Henderson, R. J. Hitzemann, S. C. Maxson, L. L. Miner, A. J. Silva, J. M. Wehner, A. Wynshaw-Boris, and R. Paylor. 1997. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132:107-124.
7. Cromphout, K., L. Keldermans, A. Snellinx, J. F. Collet, S. Grunewald, N. De Geest, R. Sciot, E. Vanschaftingen, J. Jaeken, G. Matthijs, and D. Hartmann. 2005. Tissue distribution of the murine phosphomannomutases Pmm1 and Pmm2 during brain development. Eur. J. Neurosci. 22:991-996.
8. de Lonlay, P., N. Seta, S. Barrot, B. Chabrol, V. Drouin, B. M. Gabriel, H. Journel, M. Kretz, J. Laurent, M. Le Merrer, A. Leroy, D. Pedespan, P. Sarda, N. Villeneuve, J. Schmitz, E. van Schaftingen, G. Matthijs, J. Jaeken, C. Korner, A. Munnich, J. M. Saudubray, and V. Cormier-Daire. 2001. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J. Med. Genet. 38:14-19.
9. Doucey, M. A., D. Hess, R. Cacan, and J. Hofsteenge. 1998. Protein C mannosylation is enzyme-catalyzed and uses dolichyl-phosphate-mannose as a precursor. Mol. Biol. Cell 9:291-300.
10. Drouin-Garraud, V., M. Belgrand, S. Grunewald, N. Seta, J. N. Dacher, A. Henocq, G. Matthijs, V. Cormler-Daire, T. Frebourg, and P. Saugier-Veber. 2001. Neurological presentation of a congenital disorder of glycosylation CDG-Ia: implications for diagnosis and genetic counseling. Am. J. Med. Genet. 101:46-49.
11. Grunewald, S., K. Huyben, J. G. de Jong, J. A. Smeitink, E. Rubio, G. H. Boers, H. S. Conradt, U. Wendel, and R. A. Wevers. 1999. beta-Trace protein in human cerebrospinal fluid: a diagnostic marker for N glycosylation defects in brain. Biochim. Biophys. Acta 1455:54-60.
12. Hansen, S. H., S. R, Frank, and J. E. Casanova. 1997. Cloning and characterization of human phosphomannomutase, a mammalian homologue of yeast SEC53. Glycobiology 7:829-834.
13. Heykants, L., E. Schollen, S. Grunewald, and G. Matthijs. 2001. Identification and localization of two mouse phosphomannomutase genes, Pmm1 and Pmm2. Gene 270:53-59.
14. Horoupian, D. 1995. Olivopontocerebellar atrophy in carbohydrate- deficient glycoprotein syndrome. Pediatr. Pathol. Lab. Med. 15:175-179.
15. Horslen, S. P., P. T. Clayton, B. N. Harding, N. A. Hall, G. Keir, and B. Winchester. 1991. Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. Arch. Dis. Child 66:1027-1032.
16. Jaeken, J., and H. Carchon. 2001. Congenital disorders of glycosylation: the rapidly growing tip of the iceberg. Curr. Opin. Neurol. 14:811-815.
17. Jaeken, J., G. Matthijs, H. Carchon, and E. Van Schaftingen. 2001. Defects of N-glycan synthesis, p. 1601-1622. In A. L. B. C. R. Scriver, W. S. Sly, and D. Valle (ed.), The metabolic and molecular bases of inherited diseases. McGraw-Hill Book Co., New York, N.Y.
18. Matthijs, G., E. Schollen, C. Bjursell, A. Erlandson, H. Freeze, F. Imtlaz, S. Kjaergaard, T. Martinsson, M. Schwartz, N. Seta, S. Vuillaumier-Barrot, V. Westphal, and B. Winchester. 2000. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum. Mutat. 16:386-394.
19. Matthijs, G., E. Schollen, E. Pardon, M. Veiga-Da-Cunha, J. Jaeken, J. J. Cassiman, and E. Van Schaftingen. 1997. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat. Genet. 16:88-92.
20. Matthijs, G., E. Schollen, M. Pirard, M. L. Budarf, E. Van Schaftingen, and J. J. Cassiman. 1997. PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13. Genomics 40:41-47.
21. Pirard, M., Y. Achouri, J. F. Collet, E. Schollen, G. Matthijs, and E. Van Schaftingen. 1999. Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes. Biochem. J. 339(Pt. 1):201-207.
22. Pirard, M., J. F. Collet, G. Matthijs, and E. Van Schaftingen. 1997. Comparison of PMM1 with the phosphomannomutases expressed in rat liver and in human cells. FEBS Lett. 411:251-254.
23. Pirard, M., G. Matthijs, L. Heykants, E. Schollen, S. Grunewald, J. Jaeken, and E. van Schaftingen. 1999. Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type 1A on the activity of phosphomannomutase 2. FEBS Lett. 452:319-322.
24. Pohl, S., A. Hoffmann, A. Rudiger, M. Nimtz, J. Jaeken, and H. S. Conradt. 1997. Hypoglycosylation of a brain glycoprotein (beta-trace protein) in CDG syndromes due to phosphomannomutase deficiency and N-acetylglucosaminyl- transferase 11 deficiency. Glycobiology 7:1077-1084.
25. Schollen, E., E. Pardon, L. Heykants, J. Renard, N. A. Doggett, D. F. Callen, J. J. Cassiman, and G. Matthijs. 1998. Comparative analysis of the phosphomannomutase genes PMM1, PMM2, and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene. Hum. Mol. Genet. 7:157-164.
26. 25a. Thiel, C., T. Lübke, G. Matthijs, K. von Figura, and C. Körner. 2006. Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality. Mol. Cell. Biol. 26:5615-5620.
27. Wada, Y., A. Nishikawa, N. Okamoto, K. Inui, H. Tsukamoto, S. Okada, and N. Taniguchi. 1992. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem. Biophys. Res. Commun. 189:832-836.
28. Wada, Y., and M. Sakamoto. 1997. Isolation of the human phosphomannomutase gene (PMM1) and assignment to chromosome 22q13. Genomics 39:416-417.
29. Yamashita, K., H. Ideo, T. Ohkura, K. Fukushima, I. Yuasa, K. Ohno, and K. Takeshita. 1993. Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome: evidence of asparagine-N-linked oligosaccharide transfer deficiency. J. Biol. Chem. 268:5783-5789.
30. Zentilin Boyer, M., P. de Lonlay, N. Seta, M. Besnard, C. Pelatan, H. Ogler, J. P. Hugot, C. Faure, J. M. Saudubray, J. Navarro, and J. P. Cezard. 2003. Failure to thrive and intestinal diseases in congenital disorders of glycosylation. Arch. Pediatr. 10:590-595.